Opendata, web and dolomites

PROSCOPE SIGNED

Point-of-care instrument for diagnosis and image-guided intervention of Colo-Rectal Cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PROSCOPE project word cloud

Explore the words cloud of the PROSCOPE project. It provides you a very rough idea of what is the project "PROSCOPE" about.

cancer    screening    90    entire    save    clinical    band    morphological    ionizing    proven    found    sensitive    clear    manufacturer    point    minimally    techniques    vivo    complete    rate    healthcare    death    validated    offers    recurrence    rates    polyp    optical    benefitting    incurred    modalities    light    reducing    caught    cancerous    hospital    50    care    device    endoscopes    label    planning    drastically    combination    business    develops    free    narrow    specificity    clinics    medical    proscope    time    crc    pathology    interval    vastly    video    single    treatment    probe    characterisation    detection    integrates    survival    clinicians    inadequate    gastroenterological    excisional    provides    colonoscopy    dramatically    biochemical    guided    platform    academics    biopsies    onset    sensitivity    fits    invasive    unfortunately    validation    white    smes    unmet    diagnosis    settings    thereby    imaging    image    colorectal    patients    lesions    types    chain    intervention    stage    huge    colon   

Project "PROSCOPE" data sheet

The following table provides information about the project.

Coordinator
DANMARKS TEKNISKE UNIVERSITET 

Organization address
address: ANKER ENGELUNDSVEJ 1 BYGNING 101 A
city: KGS LYNGBY
postcode: 2800
website: www.dtu.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 5˙999˙383 €
 EC max contribution 5˙999˙383 € (100%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
 Code Call H2020-ICT-2019-2
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) coordinator 1˙081˙250.00
2    MEDIZINISCHE UNIVERSITAET WIEN AT (WIEN) participant 953˙750.00
3    THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS UK (ST ANDREWS) participant 818˙143.00
4    ALBERT-LUDWIGS-UNIVERSITAET FREIBURG DE (FREIBURG) participant 685˙250.00
5    M-SQUARED LASERS LIMITED UK (GLASGOW) participant 651˙750.00
6    OVESCO ENDOSCOPY AG DE (TUBINGEN) participant 607˙631.00
7    GRINTECH GMBH DE (Jena) participant 539˙483.00
8    UNIVERSITAETSKLINIKUM FREIBURG DE (FREIBURG) participant 311˙375.00
9    Q4 PR LIMITED IE (DUBLIN 2) participant 231˙875.00
10    DIN DEUTSCHES INSTITUT FUER NORMUNG E.V. DE (BERLIN) participant 118˙875.00

Map

 Project objective

Colorectal cancer (CRC) is the second most common cause of cancer death in Europe, yet survival rates rise dramatically when caught early. A contributing factor is that current colonoscopy, i.e., white light video or optical narrow band imaging, is inadequate for in-vivo detection and characterisation of the various types of (pre-)cancerous lesions found in the colon. Point-of-care, real-time polyp diagnosis and image guided intervention has the potential to save huge healthcare costs by enabling early onset of treatment; thus reduced recurrence rate, by improving interval screening, and by reducing pathology costs incurred during colonoscopy. A complete, reliable optical diagnosis is sensitive to morphological and biochemical changes. Unfortunately, no single optical method provides both. PROSCOPE provides unique combination of label-free, non-ionizing, proven optical imaging modalities that provides higher sensitivity and specificity compared to current colonoscopy thus enabling a step-change in point-of-care management of CRC. PROSCOPE develops and integrates recent advances in optical imaging and optical probe technology into one platform. The concept is validated in clinical settings using existing endoscopes providing minimally invasive optical imaging that fits into current clinical procedures. A leading medical device manufacturer and clinicians are involved at every stage of the development and validation. PROSCOPE is driven by unmet clinical needs in the field of gastroenterological diagnosis with a clear business case: Combination of optical imaging techniques offers the potential to vastly improve early diagnosis of CRC achieving specificity and sensitivity above 90%, reducing the number of excisional biopsies by 50%, and improving interval screening planning, thereby reducing healthcare costs drastically and benefitting patients. The consortium includes five leading academics, including hospital clinics, and four SMEs covering the entire value chain.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROSCOPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROSCOPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.)

B-HUB FOR EUROPE (2020)

Blockchain HUB FOR EUROPEan startups acceleration and growth

Read More  

CloudButton (2019)

Serverless Data Analytics Platform

Read More  

EuConNeCts4 (2019)

European Conferences on Networks and Communications (EuCNC)

Read More